Published in Vasc Health Risk Manag on September 07, 2009
Metabolic syndrome in South Asians. Indian J Endocrinol Metab (2012) 1.24
Physical activity among South Asian women: a systematic, mixed-methods review. Int J Behav Nutr Phys Act (2012) 1.07
Comprehensive assessment of metabolic syndrome among rural Bangladeshi women. BMC Public Health (2012) 1.07
Prevalence of metabolic syndrome in urban India. Cholesterol (2011) 1.04
Physical activity patterns among South-Asian adults: a systematic review. Int J Behav Nutr Phys Act (2013) 1.02
Prevalence of metabolic syndrome in Iranian professional drivers: results from a population based study of 12,138 men. PLoS One (2012) 0.95
Barriers to lifestyle behavioral change in migrant South Asian populations. J Immigr Minor Health (2012) 0.88
Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India. Sultan Qaboos Univ Med J (2012) 0.87
Population-based approaches to understanding disparities in cardiovascular disease risk in the United States. Int J Gen Med (2014) 0.87
Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts. J Diabetes Res (2015) 0.83
A Comparison between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study. ISRN Endocrinol (2013) 0.79
Antiatherosclerotic effect of korean red ginseng extract involves regulator of g-protein signaling 5. Evid Based Complement Alternat Med (2014) 0.79
Effect of a physical activity intervention on the metabolic syndrome in Pakistani immigrant men: a randomized controlled trial. J Immigr Minor Health (2012) 0.77
Disparities in cardiovascular disease risk in the United States. Curr Cardiol Rev (2015) 0.77
The co-occurrence of anemia and cardiometabolic disease risk demonstrates sex-specific sociodemographic patterning in an urbanizing rural region of southern India. Eur J Clin Nutr (2015) 0.75
Objectively measured physical activity and sedentary time in south Asian women: a cross-sectional study. BMC Public Health (2014) 0.75
Metabolic syndrome in different sub occupations among mine workers. Indian J Occup Environ Med (2015) 0.75
Elevated Prevalence of Polycystic Ovary Syndrome and Cardiometabolic Disease in South Asian Infertility Patients. J Immigr Minor Health (2016) 0.75
The Association between Food Group Consumption Patterns and Early Metabolic Syndrome Risk in Non-Diabetic Healthy People. Clin Nutr Res (2017) 0.75
Comparative Study of Ultrasonographic and Anthropometric Measurements of Regional Adiposity in Metabolic Syndrome. J Clin Diagn Res (2017) 0.75
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia (1992) 13.20
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA (2005) 12.00
Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet (1991) 11.30
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics (2005) 8.99
Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia (1993) 8.86
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet (2000) 8.01
Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord (1998) 7.97
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA (2007) 6.38
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet (2001) 6.31
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation (2001) 6.29
Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet (1995) 5.79
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet (2000) 5.61
Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health Initiative. Int J Epidemiol (2006) 5.60
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med (1999) 5.59
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27
Physical activity and cardiovascular health. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. JAMA (1996) 4.89
Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol (1989) 4.53
Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med (2000) 4.43
Defining obesity cut points in a multiethnic population. Circulation (2007) 4.42
Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J (1996) 3.66
Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ (2002) 3.48
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes (2005) 3.36
Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ (1999) 3.18
Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes (1999) 2.91
Prevalence of coronary artery disease in Asian Indians. Am J Cardiol (1992) 2.90
Urban rural differences in prevalence of self-reported diabetes in India--the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract (2008) 2.85
Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab (1999) 2.78
Mortality from coronary heart disease in Asian communities in London. BMJ (1988) 2.64
Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48
Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab (2002) 2.30
Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab (1999) 2.25
Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev (2007) 2.24
Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States. Am J Cardiol (2004) 2.18
Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. CMAJ (2006) 2.13
Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease. The St James Survey, Trinidad. Lancet (1982) 2.11
Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition (2004) 2.09
Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin Cardiol (1995) 1.99
The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular disease. Obes Rev (2002) 1.92
Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation (1996) 1.91
Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ (1996) 1.90
Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol (2004) 1.83
C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation (2001) 1.81
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol (2001) 1.80
Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Göteborg. Ann Epidemiol (1997) 1.75
South Asians and cardiovascular risk: what clinicians should know. Circulation (2006) 1.74
Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health (1997) 1.73
Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond) (2006) 1.71
Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol (1989) 1.67
Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care (2003) 1.66
BMI does not accurately predict overweight in Asian Indians in northern India. Br J Nutr (2001) 1.66
Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis (1988) 1.58
Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana. Indian Heart J (2004) 1.57
Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women. Am J Clin Nutr (1999) 1.57
Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects. CMAJ (2002) 1.57
Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health (1997) 1.51
The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res (2007) 1.48
Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab (1997) 1.48
British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabet Med (2005) 1.46
Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia (1999) 1.45
Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr (2000) 1.45
Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med (2002) 1.44
C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol (2004) 1.44
Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes (2004) 1.33
Mortality of migrants from the Indian subcontinent to England and Wales: effect of duration of residence. Epidemiology (2003) 1.31
A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med (1999) 1.31
Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation (1995) 1.27
Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med (2000) 1.27
Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab (2004) 1.26
Interactions of perturbations in intrauterine growth and growth during childhood on the risk of adult-onset disease. Proc Nutr Soc (2000) 1.21
Anthropometric cut points for identification of cardiometabolic risk factors in an urban Asian Indian population. Metabolism (2007) 1.20
Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism (2003) 1.20
Computed tomography-determined body composition in relation to cardiovascular risk factors in Indian and matched Swedish males. Metabolism (1996) 1.20
Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract (2009) 1.18
Angiographic comparison of coronary artery disease between Asians and Caucasians. Postgrad Med J (1994) 1.15
Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation (1988) 1.09
Dyslipidemia in Asian Indians: determinants and significance. J Assoc Physicians India (2004) 1.08
Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein(a). Indian Heart J (1997) 1.06
Prevalence of diabetes and impaired fasting glucose in urban population of Bangladesh. Bangladesh Med Res Counc Bull (2007) 1.06
Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord (2003) 1.05
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res (2001) 1.05
Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol (1997) 1.05
Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J (2000) 1.03
Heterogeneous phenotypes of insulin resistance and its implications for defining metabolic syndrome in Asian Indian adolescents. Atherosclerosis (2005) 1.02
Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes (1999) 1.00
Cardiovascular diseases and diabetes mellitus in Fiji: analysis of mortality, morbidity and risk factors. Bull World Health Organ (1984) 0.99
Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res (1987) 0.96
Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr Bull (2002) 0.95
Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol (2005) 2.49
Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am J Cardiol (2009) 2.21
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation (2004) 1.93
Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation (2005) 1.58
Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure. J Card Fail (2008) 1.48
Protected carotid artery stenting in patients at high risk for carotid endarterectomy. South Med J (2011) 1.38
A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich) (2010) 1.18
Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. Am J Cardiol (2009) 1.17
Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation (2003) 1.11
Benefits of yoga for African American heart failure patients. Med Sci Sports Exerc (2010) 1.00
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study. J Cardiovasc Pharmacol Ther (2011) 0.91
Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease. Am J Cardiol (2003) 0.90
Lipoic acid protects against reperfusion injury in the early stages of cerebral ischemia. Brain Res (2010) 0.90
Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure. J Card Fail (2005) 0.89
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular disease. Future Cardiol (2007) 0.88
Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation). Am J Cardiol (2002) 0.87
Cellular mechanisms by which lipoic acid confers protection during the early stages of cerebral ischemia: a possible role for calcium. Neurosci Res (2010) 0.83
Raising HDL cholesterol in women. Int J Womens Health (2010) 0.83
Efficacy of controlled-release niacin in treatment of metabolic syndrome: Correlation to surrogate markers of atherosclerosis, vascular reactivity, and inflammation. J Clin Lipidol (2007) 0.81
Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use. J Cardiovasc Pharmacol Ther (2010) 0.80
Cocaine use in an urban medical population and the development of angiographically significant coronary artery disease. Prev Cardiol (2006) 0.79
Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vasc Health Risk Manag (2007) 0.79
Apocynin may limit total cell death following cerebral ischemia and reperfusion by enhancing apoptosis. Food Chem Toxicol (2011) 0.78
Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function. J Clin Hypertens (Greenwich) (2009) 0.78
The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome. Prev Cardiol (2007) 0.78
Revisiting niacin: reviewing the evidence. J Clin Lipidol (2007) 0.77
Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin. Vasc Health Risk Manag (2008) 0.77
UPEI-100, a conjugate of lipoic acid and apocynin, mediates neuroprotection in a rat model of ischemia/reperfusion. Am J Physiol Regul Integr Comp Physiol (2012) 0.77
Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model. Cardiol Res Pract (2012) 0.76
Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial. J Clin Hypertens (Greenwich) (2013) 0.76
Lifestyle risk factors and cardiovascular disease in cubans and cuban americans. Cardiol Res Pract (2011) 0.76
Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA study. J Cardiovasc Pharmacol Ther (2012) 0.76
Letter by Hammoud et al regarding article "Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition". Circulation (2007) 0.75
Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis? J Med Food (2010) 0.75
Do the current medical and economic times dictate the need for the "polypill"? J Clin Hypertens (Greenwich) (2009) 0.75
Mechanisms of benefit of angiotensin receptor blockers in coronary atherosclerosis. Am J Med Sci (2008) 0.75
Management of the statin-intolerant patient. Curr Treat Options Cardiovasc Med (2009) 0.75
Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis. Future Cardiol (2006) 0.75
Evidence-based management of acute myocardial infarction in the elderly--current perspectives. MedGenMed (2005) 0.75
Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartan. J Am Soc Hypertens (2013) 0.75
Effects of angiotensin-converting enzyme inhibitor therapy on levels of inflammatory markers in response to exercise-induced stress: studies in the metabolic syndrome. J Cardiometab Syndr (2008) 0.75
Atorvastatin: beyond lipid-lowering effects in the diabetic population. Future Cardiol (2006) 0.75